Receptor

Edit

Psychology says people who don't like chocolate aren't strange, their taste receptors may be looking ...

The Economic Times 12 Jul 2026

Psychology suggests that people who don't like chocolate aren't necessarily unusual or overly selective. Sometimes, disliking chocolate simply means the brain experiences flavor differently, not that anything is wrong ... .

Edit

Psychology says people who don't like chocolate aren't strange, their taste receptors may be looking for something different

The Times of India 12 Jul 2026

.

Edit

Mellizos reincorporan al receptor Ryan Jeffers tras casi 2 meses en la lista de lesionados

Lancaster Online 11 Jul 2026

MINNEAPOLIS (AP) — Los Mellizos de Minnesota anunciaron que el receptor Ryan Jeffers fue reincorporado el viernes de la lista de lesionados de 10 días, después de perderse casi dos meses por una fractura del hueso ganchoso de la mano ... .

Edit

Hengrui Pharma Announces Positive Topline Data from Two Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535 (Jiangsu Hengrui Medicine Co Ltd)

Public Technologies 07 Jul 2026

HRS-7535 (being developed by Kailera as KAI-7535) is a small molecule GLP-1 receptor agonist, which was designed to improve upon the clinical profile of existing oral treatments.

Edit

Post-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight

PR Newswire 07 Jul 2026

MBX Biosciences' Imapextide (MBX 1416) is a long-acting GLP-1 receptor antagonist peptide developed to reduce excessive insulin secretion and prevent recurrent hypoglycemic events in patients with PBH.

Edit

Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

PR Newswire 06 Jul 2026

ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting three validated targets of amylin receptor, GLP-1R and GIPR.

Edit

Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist

Times Argus 29 Jun 2026

The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain ....

Edit

The mechanism for ligand activation of the Smoothened G protein–coupled receptor

PNAS 29 Jun 2026

.

Edit

Story Time with Reavis: Taste receptors change as the years pass

The Paris News 28 Jun 2026

‘This Dr Pepper doesn’t taste right.” ....

Edit

IIT-K team solves mystery of atypical drug target receptor

The Times of India 25 Jun 2026

Comments. +Text SizeSmallMediumLarge. .

Edit

Drug peptides defy shape rules, activating receptors without full spiral form

Phys Dot Org 24 Jun 2026

Most of the information is contained in molecules that engage with receptor proteins on cell surfaces ... transfer at specific receptor proteins.

Edit

A receptor-like mechanosensitive protein governs preprophase band positioning for asymmetric cell divisions and SC morphogenesis

PNAS 24 Jun 2026

.

Edit

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) (Form 8-K) (Absci Corporation)

Public Technologies 24 Jun 2026

) Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) ... investigational anti-prolactin receptor (PRLR) antibody.

Edit

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults

PR Newswire 24 Jun 2026

"Therapies that target amylin and calcitonin receptors may potentially be used alone or in combination with GLP-1 or dual GLP-1/GIP agonists to improve the induction of weight loss as well as for longer-term weight management.

Edit

A receptor kinase complex refines cambium activity in Arabidopsis

PNAS 22 Jun 2026

The central component of this ... .

Podcasts:

Latest News for: receptor

Psychology says people who don't like chocolate aren't strange, their taste receptors may be looking ...

Psychology says people who don't like chocolate aren't strange, their taste receptors may be looking for something different

Mellizos reincorporan al receptor Ryan Jeffers tras casi 2 meses en la lista de lesionados

Hengrui Pharma Announces Positive Topline Data from Two Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535 (Jiangsu Hengrui Medicine Co Ltd)

Post-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight

Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist

The mechanism for ligand activation of the Smoothened G protein–coupled receptor

Story Time with Reavis: Taste receptors change as the years pass

IIT-K team solves mystery of atypical drug target receptor

Drug peptides defy shape rules, activating receptors without full spiral form

A receptor-like mechanosensitive protein governs preprophase band positioning for asymmetric cell divisions and SC morphogenesis

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) (Form 8-K) (Absci Corporation)

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults

A receptor kinase complex refines cambium activity in Arabidopsis

Article Search

EXPLORE WN.com